Business Wire
BusinessAMD says Instinct AI systems are now operating in Saudi Arabia, highlighting a potential ramp tied to additional data-center powerThe Apex TimesBusinessCostco and Old Navy promotions, Apple leadership change, and other retail and tech themes surfaced in a market roundupThe Apex TimesBusinessDeere named among stocks making notable moves in late-Thursday trading recapThe Apex TimesBusinessSalesforce says AI-driven revenue momentum is building as Agentforce adoption spreadsThe Apex TimesBusinessSalesforce backs HiBob to bolster workforce AI, and adds a new AgentExchange email toolThe Apex TimesBusinessEverPass Media expands NFL distribution via multi-year Netflix deal for 2026 slateThe Apex TimesBusinessUnitedHealth shares rise as it moves to drop prior-authorization checks for about 30% of servicesThe Apex TimesBusinessBerkshire Hathaway CEO Greg Abel to Appear on TV in Rare Interview, With Focus Likely on Insurance and BNSFThe Apex TimesBusinessCoinbase expands Webull crypto trading footprint into CanadaThe Apex TimesBusinessBroadcom leans harder into VMware AI with a push aimed at enterprise rivalsThe Apex TimesBusinessModerna shares jump after GSK advances a rival mRNA flu vaccine to Phase IIIThe Apex TimesBusinessYahoo Finance points to “buy zones” for Microsoft, Palantir, Shopify and ServiceNowThe Apex TimesBusinessAMD says Instinct AI systems are now operating in Saudi Arabia, highlighting a potential ramp tied to additional data-center powerThe Apex TimesBusinessCostco and Old Navy promotions, Apple leadership change, and other retail and tech themes surfaced in a market roundupThe Apex TimesBusinessDeere named among stocks making notable moves in late-Thursday trading recapThe Apex TimesBusinessSalesforce says AI-driven revenue momentum is building as Agentforce adoption spreadsThe Apex TimesBusinessSalesforce backs HiBob to bolster workforce AI, and adds a new AgentExchange email toolThe Apex TimesBusinessEverPass Media expands NFL distribution via multi-year Netflix deal for 2026 slateThe Apex TimesBusinessUnitedHealth shares rise as it moves to drop prior-authorization checks for about 30% of servicesThe Apex TimesBusinessBerkshire Hathaway CEO Greg Abel to Appear on TV in Rare Interview, With Focus Likely on Insurance and BNSFThe Apex TimesBusinessCoinbase expands Webull crypto trading footprint into CanadaThe Apex TimesBusinessBroadcom leans harder into VMware AI with a push aimed at enterprise rivalsThe Apex TimesBusinessModerna shares jump after GSK advances a rival mRNA flu vaccine to Phase IIIThe Apex TimesBusinessYahoo Finance points to “buy zones” for Microsoft, Palantir, Shopify and ServiceNowThe Apex TimesBusinessAMD says Instinct AI systems are now operating in Saudi Arabia, highlighting a potential ramp tied to additional data-center powerThe Apex TimesBusinessCostco and Old Navy promotions, Apple leadership change, and other retail and tech themes surfaced in a market roundupThe Apex TimesBusinessDeere named among stocks making notable moves in late-Thursday trading recapThe Apex TimesBusinessSalesforce says AI-driven revenue momentum is building as Agentforce adoption spreadsThe Apex TimesBusinessSalesforce backs HiBob to bolster workforce AI, and adds a new AgentExchange email toolThe Apex TimesBusinessEverPass Media expands NFL distribution via multi-year Netflix deal for 2026 slateThe Apex TimesBusinessUnitedHealth shares rise as it moves to drop prior-authorization checks for about 30% of servicesThe Apex TimesBusinessBerkshire Hathaway CEO Greg Abel to Appear on TV in Rare Interview, With Focus Likely on Insurance and BNSFThe Apex TimesBusinessCoinbase expands Webull crypto trading footprint into CanadaThe Apex TimesBusinessBroadcom leans harder into VMware AI with a push aimed at enterprise rivalsThe Apex TimesBusinessModerna shares jump after GSK advances a rival mRNA flu vaccine to Phase IIIThe Apex TimesBusinessYahoo Finance points to “buy zones” for Microsoft, Palantir, Shopify and ServiceNowThe Apex TimesBusinessAMD says Instinct AI systems are now operating in Saudi Arabia, highlighting a potential ramp tied to additional data-center powerThe Apex TimesBusinessCostco and Old Navy promotions, Apple leadership change, and other retail and tech themes surfaced in a market roundupThe Apex TimesBusinessDeere named among stocks making notable moves in late-Thursday trading recapThe Apex TimesBusinessSalesforce says AI-driven revenue momentum is building as Agentforce adoption spreadsThe Apex TimesBusinessSalesforce backs HiBob to bolster workforce AI, and adds a new AgentExchange email toolThe Apex TimesBusinessEverPass Media expands NFL distribution via multi-year Netflix deal for 2026 slateThe Apex TimesBusinessUnitedHealth shares rise as it moves to drop prior-authorization checks for about 30% of servicesThe Apex TimesBusinessBerkshire Hathaway CEO Greg Abel to Appear on TV in Rare Interview, With Focus Likely on Insurance and BNSFThe Apex TimesBusinessCoinbase expands Webull crypto trading footprint into CanadaThe Apex TimesBusinessBroadcom leans harder into VMware AI with a push aimed at enterprise rivalsThe Apex TimesBusinessModerna shares jump after GSK advances a rival mRNA flu vaccine to Phase IIIThe Apex TimesBusinessYahoo Finance points to “buy zones” for Microsoft, Palantir, Shopify and ServiceNowThe Apex Times
Back to front
Silo Pharma subsidiary QwikAgents joins AMD AI Developer Program, aiming to scale its AI agent platform
The Apex Times

THE APEX TIMES

Business/The Apex Times/Jul 14, 11:25 AM EDT

Silo Pharma subsidiary QwikAgents joins AMD AI Developer Program, aiming to scale its AI agent platform

Silo Pharma said its wholly owned subsidiary QwikAgents has entered AMD’s AI Developer Program, a move it frames as an effort to accelerate development of its AI agent platform.

Silo Pharma (NASDAQ:SMPL) announced that its wholly owned subsidiary, QwikAgents, has joined AMD’s AI Developer Program, saying the program will give QwikAgents access to AI development resources intended to support the expansion of its AI agent platform.

The news comes through a market update published by Yahoo Finance. In the company statement referenced by the post, QwikAgents is positioned as the vehicle for advancing Silo Pharma’s AI-driven approach, with the AMD program described as a way to speed technical development and capability building.

AMD’s AI Developer Program is presented in the announcement as a resource channel for developers working on AI applications and infrastructure. For QwikAgents, the practical outcome the company highlights is improved support for building and scaling its AI agents, rather than a specific product release date or a named deployment customer.

QwikAgents is not described in detail in the posting beyond its role in developing the AI agent platform and Silo Pharma’s overall strategy around that platform. The announcement also does not spell out whether QwikAgents will use the AMD program primarily for model development, deployment optimization, tooling, or other technical workstreams.

For the broader sector, partnerships that connect AI startups and application builders to semiconductor ecosystems are increasingly common. They typically aim to reduce friction in adopting new AI hardware and software capabilities, and they can shorten the time between early prototypes and production-ready systems. In this case, the linkage is between AMD’s developer-facing program and a health-related company’s internal platform work.

What is not disclosed in the market update is also important. The post does not provide the specific benefits QwikAgents expects to receive, such as access to particular hardware instances, software stacks, cloud credits, model-optimization services, or engineering support. It also does not disclose any financial terms, milestone-based commitments, or expected timelines for when expanded capabilities will translate into revenue or clinical or product outcomes.

Investors and observers will likely watch for follow-through details, such as whether Silo Pharma later quantifies performance improvements from the program, describes new AI agent features, or connects progress to customer activity, research workflows, or commercialization milestones. Until those additions appear, the announcement largely functions as an indicator that Silo Pharma is pursuing technical acceleration for its AI agent platform through AMD’s developer ecosystem.

Why It Matters

  • The partnership indicates Silo Pharma is seeking external AI ecosystem support to build and scale an AI agent platform.
  • AMD’s developer programs can help AI builders reduce development friction, which may improve time-to-iteration for agent features.
  • The lack of disclosed specifics means the near-term impact on products, timelines, or revenue remains unclear.
  • Further disclosures could clarify whether the collaboration results in technical milestones or operational deployment that investors can track.

Sources

Key Facts

  • Silo Pharma said its wholly owned subsidiary QwikAgents joined AMD’s AI Developer Program.
  • The company described the program as providing access to AI development resources intended to support expansion of QwikAgents’ AI agent platform.
  • The announcement was reported via a Yahoo Finance market update dated July 14, 2026.
  • The posting does not include specific technical details, financial terms, or a timetable for measurable outcomes.
  • No named AMD product, hardware configuration, or deliverable was specified in the referenced post.

Technology Related

Silo Pharma subsidiary QwikAgents joins AMD AI Developer Program, aiming to scale its AI agent platform | The Apex Times